White matter microstructure is associated with hyperactive/inattentive symptomatology and polygenic risk for attention-deficit/hyperactivity disorder in a population-based sample of adolescents.


Journal

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
ISSN: 1740-634X
Titre abrégé: Neuropsychopharmacology
Pays: England
ID NLM: 8904907

Informations de publication

Date de publication:
08 2019
Historique:
received: 23 12 2018
accepted: 30 03 2019
revised: 24 02 2019
pubmed: 6 4 2019
medline: 18 3 2020
entrez: 6 4 2019
Statut: ppublish

Résumé

Few studies have investigated the link between putative biomarkers of attention-deficit/hyperactivity disorder (ADHD) symptomatology and genetic risk for ADHD. To address this, we investigate the degree to which ADHD symptomatology is associated with white matter microstructure and cerebral cortical thickness in a large population-based sample of adolescents. Critically, we then test the extent to which multimodal correlates of ADHD symptomatology are related to ADHD polygenic risk score (PRS). Neuroimaging, genetic, and behavioral data were obtained from the IMAGEN study. A dimensional ADHD composite score was derived from multi-informant ratings of ADHD symptomatology. Using tract-based spatial statistics, whole brain voxel-wise regressions between fractional anisotropy (FA) and ADHD composite score were calculated. Local cortical thickness was regressed on ADHD composite score. ADHD PRS was based on a very recent genome-wide association study, and calculated using PRSice. ADHD composite score was negatively associated with FA in several white matter pathways, including bilateral superior and inferior longitudinal fasciculi (p < 0.05, corrected). ADHD composite score was negatively associated with orbitofrontal cortical thickness (p < 0.05, corrected). The ADHD composite score was correlated with ADHD PRS (p < 0.001). FA correlates of ADHD symptomatology were significantly associated with ADHD PRS, whereas cortical thickness correlates of ADHD symptomatology were unrelated to ADHD PRS. Variation in hyperactive/inattentive symptomatology was associated with white matter microstructure, which, in turn, was related to ADHD PRS. Results suggest that genetic risk for ADHD symptomatology may be tied to biological processes affecting white matter microstructure.

Identifiants

pubmed: 30952157
doi: 10.1038/s41386-019-0383-y
pii: 10.1038/s41386-019-0383-y
pmc: PMC6784993
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1597-1603

Subventions

Organisme : NIMH NIH HHS
ID : L40 MH108486
Pays : United States
Organisme : Medical Research Council
ID : MR/R00465X/1
Pays : United Kingdom
Organisme : MRF
ID : MRF_MRF-058-0004-RG-DESRI
Pays : United Kingdom

Références

Arch Gen Psychiatry. 2006 May;63(5):540-9
pubmed: 16651511
Neuropsychopharmacology. 2015 Feb;40(3):746-54
pubmed: 25241803
Hum Brain Mapp. 2002 Nov;17(3):143-55
pubmed: 12391568
Dialogues Clin Neurosci. 2012 Mar;14(1):29-37
pubmed: 22577302
Biol Psychiatry. 2011 Aug 1;70(3):255-62
pubmed: 21664605
J Am Acad Child Adolesc Psychiatry. 2001 Nov;40(11):1337-45
pubmed: 11699809
IEEE Trans Med Imaging. 2007 Nov;26(11):1585-97
pubmed: 18041273
Nat Rev Dis Primers. 2015 Aug 06;1:15020
pubmed: 27189265
Biol Psychiatry. 2013 Oct 15;74(8):591-8
pubmed: 23566821
Neuroimage. 2004;23 Suppl 1:S189-95
pubmed: 15501088
NMR Biomed. 2002 Nov-Dec;15(7-8):435-55
pubmed: 12489094
J Child Psychol Psychiatry. 2000 Jul;41(5):645-55
pubmed: 10946756
Dev Psychopathol. 2017 Aug;29(3):751-758
pubmed: 27297294
Cereb Cortex. 2009 Nov;19(11):2728-35
pubmed: 19299253
Am J Psychiatry. 2011 Apr;168(4):365-77
pubmed: 21324949
Neuroimage. 2009 Jan 1;44(1):83-98
pubmed: 18501637
Biol Psychiatry. 2017 Nov 1;82(9):660-668
pubmed: 28237458
Magn Reson Med. 2001 Feb;45(2):191-5
pubmed: 11180424
Am J Med Genet B Neuropsychiatr Genet. 2013 Jul;162B(5):419-430
pubmed: 23728934
Sci Rep. 2016 Sep 06;6:33015
pubmed: 27597294
Bioinformatics. 2015 May 1;31(9):1466-8
pubmed: 25550326
Neuropsychology. 2004 Jul;18(3):543-55
pubmed: 15291732
J Neurosci. 2013 Jan 2;33(1):244-58
pubmed: 23283338
Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19649-54
pubmed: 18024590
Nat Genet. 2019 Jan;51(1):63-75
pubmed: 30478444
PLoS Genet. 2013 Mar;9(3):e1003348
pubmed: 23555274
Am J Med Genet B Neuropsychiatr Genet. 2004 Jan 1;124B(1):41-7
pubmed: 14681911
Neuroimage. 2006 Jul 15;31(4):1487-505
pubmed: 16624579
J Am Acad Child Adolesc Psychiatry. 2014 Oct;53(10):1123-9.e6
pubmed: 25245356
J Am Acad Child Adolesc Psychiatry. 2014 Jul;53(7):790-9.e3
pubmed: 24954828
Neuropsychopharmacology. 2019 Jan;44(1):226-227
pubmed: 30194422
Cereb Cortex. 2019 May 1;29(5):1866-1874
pubmed: 29912404
Mol Psychiatry. 2019 Apr;24(4):562-575
pubmed: 29892054
Neuroimage. 2004;23 Suppl 1:S208-19
pubmed: 15501092
Am J Psychiatry. 2011 Feb;168(2):143-51
pubmed: 21159727
J Child Psychol Psychiatry. 1997 Jul;38(5):581-6
pubmed: 9255702
Science. 2013 Nov 22;342(6161):987-91
pubmed: 24179158
Eur J Neurosci. 2010 Mar;31(5):912-9
pubmed: 20374289
Front Neuroinform. 2014 May 21;8:54
pubmed: 24904400
Atten Defic Hyperact Disord. 2015 Mar;7(1):27-38
pubmed: 24942707
Prog Neuropsychopharmacol Biol Psychiatry. 2015 Dec 3;63:14-22
pubmed: 25956761
Int J Methods Psychiatr Res. 2007;16 Suppl 1:S16-23
pubmed: 17623391
Proc Natl Acad Sci U S A. 2014 Sep 30;111(39):14253-8
pubmed: 25225386
Mol Psychiatry. 2010 Dec;15(12):1128-39
pubmed: 21102431
J Am Acad Child Adolesc Psychiatry. 2012 Jan;51(1):18-27.e2
pubmed: 22176936
Pediatrics. 2015 Apr;135(4):e994-1001
pubmed: 25733754
J Int Neuropsychol Soc. 2009 May;15(3):331-43
pubmed: 19402919

Auteurs

Matthew D Albaugh (MD)

Department of Psychiatry, Vermont Center for Children, Youth, and Families, University of Vermont College of Medicine, Burlington, VT, USA. malbaugh@uvm.edu.

James J Hudziak (JJ)

Department of Psychiatry, Vermont Center for Children, Youth, and Families, University of Vermont College of Medicine, Burlington, VT, USA.

Alex Ing (A)

Medical Research Council - Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Bader Chaarani (B)

Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT, USA.

Edward Barker (E)

Medical Research Council - Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Tianye Jia (T)

Medical Research Council - Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Herve Lemaitre (H)

Institut National de la Santé et de la Recherche Médicale, UMR 992 INSERM, CEA, Faculté de médecine, Université Paris-Sud, Université Paris-Saclay, NeuroSpin, F-91191, Gif-sur-Yvette, France.

Richard Watts (R)

Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT, USA.

Catherine Orr (C)

Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT, USA.

Philip A Spechler (PA)

Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT, USA.

Claude Lepage (C)

McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.

Vladimir Fonov (V)

McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.

Louis Collins (L)

McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.

Pierre Rioux (P)

McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.

Alan C Evans (AC)

McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.

Tobias Banaschewski (T)

Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, 68159, Mannheim, Germany.

Arun L W Bokde (ALW)

Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland.

Uli Bromberg (U)

University Medical Centre Hamburg-Eppendorf, House W34, 3.OG, Martinistrasse 52, 20246, Hamburg, Germany.

Christian Büchel (C)

University Medical Centre Hamburg-Eppendorf, House W34, 3.OG, Martinistrasse 52, 20246, Hamburg, Germany.

Erin Burke Quinlan (EB)

Medical Research Council - Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Sylvane Desrivières (S)

Medical Research Council - Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Herta Flor (H)

Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, Mannheim, Germany.
Department of Psychology, School of Social Sciences, University of Mannheim, 68131, Mannheim, Germany.

Vincent Frouin (V)

NeuroSpin, CEA, Université Paris-Saclay, 91191, Gif-sur-Yvette, France.

Penny Gowland (P)

Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, UK.

Andreas Heinz (A)

Charité - Universitätsmedizin Berlin, Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charitéplatz 1, Berlin, Germany.

Bernd Ittermann (B)

Physikalisch-Technische Bundesanstalt (PTB), Abbestrasse 2 - 12, Berlin, Germany.

Jean-Luc Martinot (JL)

Institut National de la Santé et de la Recherche Médicale, INSERM Unit 1000 "Neuroimaging & Psychiatry", University Paris Sud, University Paris Descartes - Sorbonne Paris Cité; and Maison de Solenn, Paris, France.

Frauke Nees (F)

Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, 68159, Mannheim, Germany.
Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, Mannheim, Germany.

Dimitri Papadopoulos Orfanos (DP)

NeuroSpin, CEA, Université Paris-Saclay, 91191, Gif-sur-Yvette, France.

Tomáš Paus (T)

Bloorview Research Institute, Holland Bloorview Kids Rehabilitation Hospital and Departments of Psychology and Psychiatry, University of Toronto, Toronto, ON, M6A 2E1, Canada.

Luise Poustka (L)

Department of Child and Adolescent Psychiatry and Psychotherapy, University Medical Centre Göttingen, von-Siebold-Strasse 5, 37075, Göttingen, Germany.

Juliane H Fröhner (JH)

Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany.

Michael N Smolka (MN)

Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany.

Henrik Walter (H)

NeuroSpin, CEA, Université Paris-Saclay, 91191, Gif-sur-Yvette, France.

Robert Whelan (R)

School of Psychology and Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland.

Gunter Schumann (G)

Medical Research Council - Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Hugh Garavan (H)

Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT, USA.

Alexandra Potter (A)

Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH